Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

New Site for GE Cows Ignores Biosecurity Questions

GE free NZ
Press Release

New Site for GE Cows Ignores Unanswered Biosecurity Questions

There is concern that a new application by AgResearch to move transgenic cows to a new site will be approved by ERMA, despite the lack of data on impacts on soil environments.

AgResearch has previously farmed on 100 acres deemed 'in containment', but the latest application opens up a whole new stage of transgenic cattle expansion around the country and any approval of the plan is tantamount to a 'conditional release'.

ERMA have been complicit in allowing amendments under the HSNO Act that have gradually eroded the stringent approach, like allowing experimental GE cattle carrying different types of human transgenes to graze together.

ERMA has allowed through non public approvals for AgResearch to carry on breeding cows, but there have been no studies on the adverse effects that the animals have on the soil or ecosystem, only the offal pits where high levels of antibiotic resistant genes were found in the surrounding soil.

The need to research and study such data has been deliberately ignored as a key element of understanding GE biosecurity risk management, even though these animals have been continuously farmed in field development conditions for seven years.

The original approval for development trials was to see if transgenic products could be pharmed from milk, and to establish if the gene was stably passed to the first generation of calves. This was not successful in cows engineered with a gene to express myelin basic protein (MBP). Only four out of sixty calves were born. The process to produce lactogobulin was unviable. Cows carrying an extra casein gene were more productive. However when AgResearch was given permission by ERMA to import embryo's containing human lactoferrin they broke the law by using transgenic cows to carry the embryo's. Despite this breach, nothing ever came of it but a 'warning'.

"This kind of deliberate disregard shows that ERMA has no will to follow the correct procedures that the Act prescribes and the public expect," says Claire Bleakley of GE Free (NZ) in food and environment. "ERMA now see GE approvals as part of their 'bread and butter' income stream, and are side stepping sound science to enable GE expansion. It is just unbelievable that ERMA would accept an application relating to a new facility without any proof from existing trials that horizontal gene transfer, or adverse effects on humans or the environmental have not occurred.

“We fear that yet again the New Zealand public is at the mercy of big business and bureaucrats willing to ignore scientific rigour to promote certain interests, and that their mistakes will leave the taxpayer and our children to clean up the contaminated sites".

"We are alarmed that yet again ERMA looks set to go through the pretence of listening to the public and to independent scientific calls for comprehensive testing for effects in GE field studies, but in reality taking not one bit of notice and instead finding ways to discount any concerns in order to approve the application," said Mrs. Bleakley.

"When in future an adverse effect shows up they will feign astonishment and pass the buck to MAF".

REFERENCES:

AgResearch application to amend controls under s67A, GMF 98009 part I &II (2007)

ERMA s67A amendment to allow the import of lactoferrin embryos www.ermanz.govt.nz

ERMA GMD 02028 Annual reports 2004-2006 www.ermanz.govt.nz

ERMA GMF 98009 Annual reports 2001 -2006 www.ermanz.govt.nz

Background Note
To date no transgenic drug from milk has been approved for oral ingestion. Most such milk-derived products have failed because of immune system reactions and deterioration in the conditions being treated. The most famous reaction to a genetically engineered drug was during the trial of an arthritis drug that caused severe immune reaction permanently impairing the health of the subjects.


ENDS


© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Statistics: Building Activity Down In September Quarter
The volume of building activity in New Zealand fell 8.6 percent in the September 2021 quarter, compared with the June 2021 quarter, Stats NZ said today. Residential building activity fell by 6.4 percent in the September 2021 quarter, while non-residential building activity fell 12 percent... More>>


Government: David McLean Appointed As KiwiRail Chair

David McLean has been appointed as Chair of KiwiRail Holdings Ltd, the Minister for State Owned Enterprises Dr David Clark and Minister of Finance Grant Robertson announced today... More>>


Dairy NZ: ‘More Milk From Fewer Cows’ Trend Continues In A Record Year
Vodafone says it has 10,000 customers using its Wi-Fi Calling service. It took less than three months to reach that milestone; the service began operating in September... More>>



Xero: Data Reveals ICT Expenditure Key To Small Business Sales Growth
Xero, the global small business platform, today released a new report which shows New Zealand small business ICT expenditure has increased 25 percent compared to pre-pandemic levels - more than the UK (20%) and Australia... More>>


Fonterra: Lifts Forecast Farmgate Milk Price Range And Revises Earnings Guidance At First Quarter Update

Fonterra Co-operative Group today lifted its 2021/22 forecast Farmgate Milk Price range, reported a solid start to the 2022 financial year and revised its earnings guidance... More>>


Canterbury Museum: New Research - Bald Haast's Eagle Feasted On Moa Guts

New Zealand’s extinct Haast’s Eagle (Hieraaetus moorei), the largest known eagle, gulped down viscera like a vulture and may even have been bald, new research suggests... More>>

ABC Business Sales: Demand High For Covid-proof Businesses
Despite the continuing challenges facing businesses in this Covid environment, right now there are more buyers looking for a small-medium sized business than there are sellers in the market... More>>